Yahoo Finance4 天
HeartSciences Inc. (HSCS)
Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered ...
Yahoo Finance4 天
HeartSciences Inc. (HSCS)
After hours: December 24 at 2:58:52 p.m. EST ...
Special delivery nanoparticle can program stem cells while inside the body
Middlemen get a bad rap for adding cost and complications to an operation. So, eliminating the go-betweens can reduce expense ...
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Texas Tech University ...
NEW YORK, NY / ACCESSWIRE / December 23, 2024 / Texas Tech University Health Sciences Center and Texas Tech University Health Sciences Center El ...
Armed robbery in Revesby6 天
Special Delivery Nanoparticle Sidesteps 'Middlemen'
Middlemen get a bad rap for adding cost and complications to an operation. So, eliminating the go-betweens can reduce expense ...
Bemidji Now5 天
December 23 e-Cubed Is Only A Couple Months Away: Lee Furuseth Previews HSC’s Signature Event
Headwater Science Center Executive Director Lee Furuseth previews their signature event, e-Cubed. The 16th Annual Elevated ...
Yahoo Finance2 天
Co-Diagnostics, Inc. (CODX)
After hours: December 24 at 3:30:04 PM EST Loading Chart for CODX ...
Editas Medicine股价暴跌至52周新低1.27美元
Editas Medicine Inc.股价跌至52周新低，触及1.27美元，较52周高点11.58美元大幅下跌89%。这家生物科技公司目前市值仅为1.06亿美元，尽管其资产负债表健康，现金多于债务，但仍面临市场逆风。这一最新价格较之前的估值显著下降，反映出过去一年88%的急剧下跌。投资者对公司前景持谨慎态度，导致持续抛售，最终达到这一新低。根据 InvestingPro ...
腾讯网4 天
突破实体瘤难关，明年更多疗法有望获批｜ 细胞和基因疗法年度盘点 ...
▎药明康德内容团队编辑细胞和基因疗法在过去10年里长足发展，在即将过去的2024年再次迎来重要里程碑——两类细胞疗法纷纷突破实体瘤难关；同时，从获批数量来看，2024年不仅保持了过去3年中的稳健趋势，即将到来的2025年还有望开启“加速”模式，超过1 ...